CVE-2026-32869: OPEXUS eComplaint · Cross-site Scripting
Affects OPEXUS eComplaintSource CVE Database V5
Not known to be exploited · CVSS 5.1 Medium : upgrade to 10.2.0.0 when convenient.
Data as of 31 Oct 2026, 20:20 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 3% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 10.2.0.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 19 Mar 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 31 Oct 2026.
What to do
Upgrade eComplaint and eCASE to 10.2.0.0.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| OPEXUSeComplaint | Affected
| Fixed in
|
| OPEXUSeCASE | Affected
| Fixed in
|
AI-suggested
In the interim, implement strict input validation on the 'Name of Organization' field to reject or sanitize potentially malicious characters such as script tags and event handlers. Employ output encoding techniques (e.g., HTML entity encoding) when rendering user-supplied data in web pages to prevent script execution. Restrict access to case information pages to only necessary users and monitor logs for suspicious activity indicating attempted XSS exploitation. Additionally, implement Content Security Policy (CSP) headers to reduce the impact of injected scripts. Conduct security awareness training to inform users about the risks of interacting with untrusted content. Regularly audit and test web applications for similar input validation flaws to proactively identify and remediate vulnerabilities.
Description
CVE-2026-32869 is a medium-severity cross-site scripting (XSS) vulnerability in OPEXUS eComplaint and eCASE versions prior to 10.2.0.0. The flaw arises from improper sanitization of the 'Name of Organization' field during case information entry. An authenticated attacker can inject malicious scripts that execute in the context of other users' sessions when they view the affected case page. Exploitation requires authentication and some user interaction, limiting ease of attack but still posing risks to confidentiality and integrity. No known exploits are currently reported in the wild. The vulnerability affects organizations using OPEXUS eComplaint, particularly those handling sensitive case data. Mitigation involves updating to fixed versions once available and implementing strict input validation and output encoding.